The Procter & Gamble Company
161.02USD
-3.4810 (-2.12%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on PG.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.82▼ | $1.88 | 3 | 2 |
| Next quarter | $1.63▼ | $1.64 | 3 | 4 |
| Current year | $6.99▼ | $7.04 | 3 | 3 |
| Next year | $7.41▼ | $7.42 | 2 | 3 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $1.89 | $2 | +0.11 (+5.7%) |
| 2026-06-30 | $1.41 | $1.43 | +0.02 (+1.6%) |
| 2026-03-31 | $1.56 | $1.59 | +0.03 (+2.2%) |
| 2025-12-31 | $1.86 | $1.88 | +0.02 (+1.2%) |
357 ratings from 46 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Freedom Broker | Upgraded from Hold | Buy | $176 | Oct 23, 2026 |
| UBS | Maintained | Buy | $172 $190 | Oct 23, 2026 |
| Citigroup | Maintained | Buy | $180 $187 | Oct 23, 2026 |
| BNP Paribas | Maintained | Outperform | $177 $189 | Oct 23, 2026 |
| JP Morgan | Maintained | Overweight | $162 $180 | Oct 23, 2026 |
| Evercore ISI Group | Maintained | Outperform | $166 $180 | Oct 23, 2026 |
| RBC Capital | Maintained | Outperform | $166 $169 | Oct 23, 2026 |
| Wells Fargo | Maintained | Overweight | $164 $180 | Oct 23, 2026 |
| TD Cowen | Maintained | Hold | $150 $166 | Oct 23, 2026 |
| Morgan Stanley | Maintained | Overweight | $166 $185 | Oct 23, 2026 |
| RBC Capital | Reiterated | Outperform | $166 | Oct 20, 2026 |
| Citigroup | Maintained | Buy | $170 $180 | Oct 14, 2026 |
| Evercore ISI Group | Upgraded from In-Line | Outperform | $161 $166 | Oct 6, 2026 |
| RBC Capital | Maintained | Outperform | $167 $166 | Oct 6, 2026 |
| TD Cowen | Reiterated | Hold | $150 | Sep 30, 2026 |
| Argus Research | Downgraded from Buy | Hold | — | Aug 7, 2026 |
| HSBC | Downgraded from Buy | Hold | $182 $149 | Jul 30, 2026 |
| Citigroup | Maintained | Buy | $181 $170 | Jul 30, 2026 |
| Barclays | Maintained | Equal-Weight | $146 $152 | Jul 21, 2026 |
| JP Morgan | Maintained | Overweight | $164 $162 | Jul 16, 2026 |
| B of A Securities | Maintained | Buy | $170 $166 | Jul 10, 2026 |
| Bernstein | Initiated | Market Perform | $156 | Jun 11, 2026 |
| UBS | Maintained | Buy | $166 $172 | Apr 27, 2026 |
| TD Cowen | Maintained | Hold | $142 $150 | Apr 27, 2026 |
| Wells Fargo | Maintained | Overweight | $158 $164 | Apr 27, 2026 |
216 filings from 52 insiders · 42 buy / 16 sell over 6m
Officers and directors of PG, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Subramaniam RajeshDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Portman Robert JonesDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| McEvoy AshleyDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| McCarthy Christine MDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Kempczinski Christopher JDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| JIMENEZ JOSEPHDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Chang AmyDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Bonini SheilaDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Biggs M. BrettDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| ARNOLD CRAIGDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Allen Bertrand MarcDirector | Grant | 1.4k | — | — | Oct 13, 2026 |
| Schulten AndreOfficer, Chief Financial Officer | Sell | 3.9k | $145.34 | $569k | Oct 5, 2026 |
| Gama PaulOfficer, CEO- Health Care | Sell | 2.2k | $145.34 | $323k | Oct 5, 2026 |
| Whaley Susan StreetOfficer, Chief Legal Officer & Secy | Sell | 2.4k | $145.34 | $344k | Oct 5, 2026 |
| Whaley Susan StreetOfficer, Chief Legal Officer & Secy | GrantStock Option (Right to Buy) | 24.3k | — | — | Oct 1, 2026 |
| Whaley Susan StreetOfficer, Chief Legal Officer & Secy | Grant | 6.1k | — | — | Oct 1, 2026 |
| Schulten AndreOfficer, Chief Financial Officer | GrantStock Option (Right to Buy) | 78.3k | — | — | Oct 1, 2026 |
| Schulten AndreOfficer, Chief Financial Officer | Grant | 6.6k | — | — | Oct 1, 2026 |
| Gama PaulOfficer, CEO- Health Care | Grant | 12.5k | — | — | Oct 1, 2026 |
| Jejurikar ShaileshDirector; Officer, Chairman, President and CEO | GrantStock Option (Right to Buy) | 191.9k | — | — | Oct 1, 2026 |
No analyst notes on PG yet.
Analyst Ratings
23 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 9 | 11 | 0 | 0 | Buy2.24 |
| 1 mo ago | 6 | 7 | 12 | 0 | 0 | Buy2.24 |
| 2 mo ago | 6 | 7 | 12 | 0 | 0 | Buy2.24 |
| 3 mo ago | 6 | 8 | 11 | 0 | 0 | Buy2.20 |
Members whose judged calls on PG have played out most reliably.
No settled calls on PG yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice